Sponsored Advertising Content
Red Ion
Working with DICOM at scale?
DICOMAnon helps imaging teams anonymize, batch process, and automate DICOM workflows without writing custom scripts.
Author profile
Creighton University
DICOMAnon helps imaging teams anonymize, batch process, and automate DICOM workflows without writing custom scripts.
Glioblastoma (GBM) remains a lethal brain cancer with a devastating median survival of about 15 months with the current standard of treatment involving surgery, radiation therapy, and chemotherapy utilizing temozolomide (TMZ). Radioimmunotherapy (RIT), combin...
Glioblastoma is highly aggressive and the most prevalent brain tumor in adults. The median survival of patients is 15 months, despite the current standard of care comprising surgery, radiotherapy, and chemotherapy. Hence, new therapeutic approaches are urgent...